Could metal detox boost leukemia treatment? new trial aims to find out
NCT ID NCT06811233
First seen Nov 01, 2025 · Last updated Apr 24, 2026 · Updated 20 times
Summary
This study tests whether adding metal-detoxifying drugs to standard chemotherapy can improve outcomes for people with certain types of acute myeloid leukemia (AML). Researchers believe that lowering metal levels in the blood and bone marrow may help control the disease or make chemotherapy work better. About 140 adults with intermediate-risk, high-risk, or secondary AML will be randomly assigned to receive either standard therapy alone or standard therapy plus two detoxifying agents (Ca-EDTA and DMSA). The main goal is to check safety and side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA (AML) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The University of Texas M. D. Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.